HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Montoro Selected Research

Nasal Obstruction

1/2011Effect of bilastine upon nasal obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Montoro Research Topics

Disease

7Allergic Rhinitis
05/2016 - 01/2007
6Hypersensitivity (Allergy)
05/2016 - 01/2007
4Asthma (Bronchial Asthma)
07/2023 - 01/2010
4Urticaria (Hives)
01/2013 - 01/2007
3Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2015 - 01/2009
3Chronic Urticaria
01/2011 - 01/2007
2Anaphylaxis (Anaphylactic Shock)
11/2000 - 02/2000
1Hodgkin Disease (Hodgkin's Disease)
12/2023
1Lymphoma (Lymphomas)
12/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2023
1Food Hypersensitivity (Food Allergy)
05/2016
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2016
1Neoplasms (Cancer)
03/2016
1Rhinitis
01/2015
1Infections
07/2013
1Wounds and Injuries (Trauma)
02/2013
1Liver Failure
01/2013
1Amnesia (Dissociative Amnesia)
01/2013
1Conjunctivitis
01/2013
1Cardiotoxicity
01/2011
1Seasonal Allergic Rhinitis (Hay Fever)
01/2011
1Nasal Obstruction
01/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2009
1Disorders of Excessive Somnolence (Hypersomnia)
01/2009
1Inflammation (Inflammations)
01/2007
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2007
1Solar Urticaria
01/2007
1Proteinuria
01/2006
1Photoallergic Dermatitis (Photoallergy)
02/2003
1Autoimmune Diseases (Autoimmune Disease)
01/2003
1Drug Eruptions (Drug Eruption)
01/2003
1Spinal Dysraphism (Spina Bifida)
02/2000

Drug/Important Bio-Agent (IBA)

9Histamine Antagonists (Antihistamines)IBA
01/2013 - 01/2007
4bilastineIBA
01/2011 - 01/2011
4AllergensIBA
01/2011 - 01/2007
3Immunoglobulin E (IgE)IBA
01/2015 - 02/2000
3fexofenadine (Allegra)FDA LinkGeneric
01/2011 - 01/2011
3desloratadine (Aerius)FDA LinkGeneric
01/2011 - 01/2011
2Histamine (Histamine Dihydrochloride)FDA Link
01/2015 - 01/2007
2Hypnotics and Sedatives (Sedatives)IBA
01/2013 - 01/2011
2Cetirizine (Zyrtec)FDA LinkGeneric
01/2011 - 01/2011
2levocetirizineFDA LinkGeneric
01/2011 - 01/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2009 - 02/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023
1Biomarkers (Surrogate Marker)IBA
05/2016
1Paclitaxel (Taxol)FDA LinkGeneric
03/2016
1Adenosine (Adenocard)FDA LinkGeneric
01/2015
1Methacholine Chloride (Methacholine)FDA Link
01/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2015
1Phentolamine (Z-Max)FDA LinkGeneric
01/2015
1Mannitol (Osmitrol)FDA LinkGeneric
01/2015
1Antiviral Agents (Antivirals)IBA
07/2013
1ElementsIBA
02/2013
1rupatadineIBA
01/2011
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
01/2009
1Cholinergic Antagonists (Anticholinergics)IBA
01/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2007
1Vehicle Emissions (Emissions, Vehicle)IBA
01/2007
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2007
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2007
1CreatinineIBA
01/2006
1Diclofenac (SR 38)FDA LinkGeneric
02/2003
1Piroxicam (Feldene)FDA LinkGeneric
01/2003
1Excipients (Suspending Agents)IBA
11/2000
1Carboxymethylcellulose Sodium (Polycell)FDA Link
11/2000
1LatexIBA
02/2000
1ParamethasoneIBA
02/2000

Therapy/Procedure

3Therapeutics
03/2016 - 01/2007
2Transplantation
12/2023 - 03/2016
1Hematopoietic Stem Cell Transplantation
12/2023
1Dry Powder Inhalers
07/2023
1Nebulizers and Vaporizers (Inhaler)
07/2023
1Diet Therapy (Therapy, Diet)
05/2016
1Induction Chemotherapy
03/2016
1Drug Therapy (Chemotherapy)
03/2016
1Salvage Therapy
03/2016
1Immunotherapy
01/2010
1Intra-Articular Injections
11/2000